China’s Sinovac Vaccine 67% Effective for Symptomatic Infection

SANTIAGO (Reuters) – Sinovac’s COVID-19 vaccine CoronaVac was 67% effective in preventing symptomatic infection in the first real-world study of the Chinese shot, the Chilean government said on Friday. The vaccine was 85% effective in preventing hospitalizations and 80% effective in preventing deaths, the government said in a report prepared…

UK: Lockdown, Not Vaccines, Behind Drop in COVID Deaths

LONDON (Reuters) – British Prime Minister Boris Johnson warned on Tuesday that the rapid drop in COVID-19 deaths was largely down to a three-month lockdown, not the vaccination programme, and that cases would rise once again as restrictions ease. The United Kingdom launched its inoculation drive in December and has…

COVID-19 Vaccination Strategies Suggested for Patients on Antirheumatic Immunosuppressive Therapy

NEW YORK (Reuters Health) – UK experts propose evidence-based management strategies for rheumatology patients on immunosuppressive therapy, including delaying/postponing rituximab, as appropriate. “The aim of this viewpoint article is to outline the existing data on the effect of antirheumatic therapy on vaccine responses in patients with inflammatory arthritis, and to…